Compare Stocks → You need to know these two things about AI stocks ASAP… (From InvestorPlace) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CGIXNASDAQ:CHEKOTCMKTS:FZMD Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGIXCancer Genetics$0.19$0.26$2.11▼$17.50$792K2.722.44 million shs19,116 shsCHEKCheck-Cap$2.26+1.8%$2.26$1.30▼$4.63$13.22M0.45186,671 shs4,642 shsFZMDFuse Medical$0.10$0.10$0.05▼$0.25$7.02M-0.274,721 shs9,509 shsBeginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGIXCancer Genetics0.00%0.00%0.00%0.00%+19,399,900.00%CHEKCheck-Cap+1.80%+0.44%-11.02%+2.73%+23.50%FZMDFuse Medical0.00%0.00%-11.63%+5.32%+171.43%You need to know these two things about AI stocks ASAP… (Ad)For 40 years, he's been known as one of the world's most bullish investors. Forbes even referred to him a "perma bull"... But he just shocked the world by issuing a massive bear warning about AI stocks.Go here now for this breaking story.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCGIXCancer GeneticsN/AN/AN/AN/AN/AN/AN/AN/ACHEKCheck-CapN/AN/AN/AN/AN/AN/AN/AN/AFZMDFuse MedicalN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCGIXCancer GeneticsN/AN/AN/AN/ACHEKCheck-Cap2.00HoldN/AN/AFZMDFuse MedicalN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCGIXCancer Genetics$6.33M0.13N/AN/AN/A∞CHEKCheck-CapN/AN/AN/AN/A$8.57 per shareN/AFZMDFuse Medical$18.65M0.38N/AN/AN/A∞Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCGIXCancer GeneticsN/A-$2.07N/A∞N/AN/AN/AN/AN/ACHEKCheck-Cap-$19.11M-$3.02N/A∞N/AN/A-47.85%-43.50%N/AFZMDFuse Medical$3.10M$0.051.90∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCGIXCancer GeneticsN/AN/AN/AN/AN/ACHEKCheck-CapN/AN/AN/AN/AN/AFZMDFuse MedicalN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCGIXCancer GeneticsN/AN/AN/ACHEKCheck-CapN/A17.6017.60FZMDFuse MedicalN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCGIXCancer Genetics8.92%CHEKCheck-Cap1.07%FZMDFuse MedicalN/AInsider OwnershipCompanyInsider OwnershipCGIXCancer Genetics15.00%CHEKCheck-Cap0.48%FZMDFuse Medical92.25%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCGIXCancer GeneticsN/A4.09 millionN/ANot OptionableCHEKCheck-Cap855.85 million5.82 millionNot OptionableFZMDFuse MedicalN/A73.90 million5.73 millionNot OptionableCHEK, FZMD, CGIX, NC6, and SUD HeadlinesSourceHeadlineAmazon Freevee Developing Medical Procedural From Adam Sussman & Mark Perezmsn.com - May 2 at 2:15 AMMedical Treatmentsnpr.org - February 13 at 2:47 AMFuse Medical Inc FZMDmorningstar.com - February 6 at 1:49 PMFuse Oncology Announces Strategic Collaboration with Radiation Oncology Leadermarkets.businessinsider.com - December 14 at 10:48 PM7 Best Selling Automotive Fuse Holders for 2023jpost.com - November 19 at 10:02 AMCan You Solve The Mystery Of A Chevy Silverado HD That Kept Blowing Fuse Blocks?jalopnik.com - November 4 at 2:03 PMMedical News | Medpage Todaymedpagetoday.com - October 23 at 10:53 PMLittelfuse launches its Class J Fuse Disconnect Switchelectronics360.globalspec.com - October 6 at 12:54 PMFuse Oncology Unveils FuseDocs: Newest RadOnc Solution for Streamlining Clinical Documentation for Radiation Oncologistsmarkets.businessinsider.com - September 29 at 2:07 PMFuse Medical nets $5M in 2nd quarterbeckersspine.com - August 15 at 6:43 PMFuse Medical, Inc. Announces Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 15 at 6:43 PMZelda: Tears Of The Kingdom Best Fuse Combinationssegmentnext.com - July 21 at 7:14 PMA Fuse Is Just A Fuse, Right?hackaday.com - July 6 at 7:59 AMSports Medicine News and Researchnews-medical.net - June 7 at 10:31 AMCircuit Breaker & Fuse Market size to hit USD 23.51 Bn by 2029 at a CAGR 5.3 percent – says Maximize Market Researchbenzinga.com - June 5 at 12:54 PMHow To Get Fuse In Zelda: Tears Of The Kingdomsegmentnext.com - June 1 at 2:32 AMPPTC Resettable Fuse Market Size by 2031marketwatch.com - April 22 at 9:17 AMFuse Medical, Inc. Fiscal Year 2022 Financial Resultsfinance.yahoo.com - April 18 at 10:50 AMWriting A FUSE Filesystem In Pythonhackaday.com - April 17 at 2:31 PMsecurity fuseshackaday.com - April 16 at 9:08 AMDetailed Analysis of Electric Vehicle Fuses Market Forecast 2023 to 2027marketwatch.com - April 8 at 12:11 AMFormer Need For Speed Developers Form New Studio Called Fuse Gamesgamespot.com - March 19 at 12:10 AMResettable Fuses Market Research Report by Vertical, Application, Region - Global Forecast to 2030- Cumulative Impact of COVID-19marketwatch.com - March 7 at 5:12 PMAutomotive Fuse Global Market Report 2023: Rise in Sales of Premium Vehicles Offers Excellent Growth Opportunitiesfinance.yahoo.com - February 20 at 2:34 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsCancer GeneticsNASDAQ:CGIXVyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The firm's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Its programs are focused on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome, CDKL5 Deficiency Disorders, and familial Parkinson's Disease. The company was founded on April 8, 1999 and is headquartered in Cherry Hill, NJ.Check-CapNASDAQ:CHEKCheck-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.Fuse MedicalOTCMKTS:FZMDFuse Medical, Inc. manufactures and distributes medical devices in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
